EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

IncidencePrevalence : An R package to calculate population‐level incidence rates and prevalence using the OMOP common data model

Berta Raventós iD, Martí Català iD, Mike Du iD, Yuchen Guo iD, Adam Black iD, Ger Inberg iD, Xintong Li iD, Kim López-Güell iD, Danielle Newby iD, Maria de Ridder iD, Cesar Barboza iD, Talita Duarte-Salles iD und 4 weitere

Pharmacoepidemiology and Drug Safety · 2024-01 · 33 (1)

DOI: 10.1002/pds.5717 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmacoepidemiology and Drug Safety, online erschienen am 25.10.2023. Verfasst von Berta Raventós und 15 weiteren Autor:innen. Beteiligte Einrichtung: Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain. Hauptthemen laut MEDLINE: Data Management, COVID-19. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: European Medicines Agency.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Real‐world data (RWD) offers a valuable resource for generating population‐level disease epidemiology metrics. We aimed to develop a well‐tested and user‐friendly R package to compute incidence rates and prevalence in data mapped to the observational medical outcomes partnership (OMOP) common data model (CDM). Materials and Methods We created IncidencePrevalence, an R package to support the analysis of population‐level incidence rates and point‐ and period‐prevalence in OMOP‐formatted data. On top of unit testing, we assessed the face validity of the package. To do so, we calculated incidence rates of COVID‐19 using RWD from Spain (SIDIAP) and the United Kingdom (CPRD Aurum), and replicated two previously published studies using data from the Netherlands (IPCI) and the United Kingdom (CPRD Gold). We compared the obtained results to those previously published, and measured execution times by running a benchmark analysis across databases.

Results

IncidencePrevalence achieved high agreement to previously published data in CPRD Gold and IPCI, and showed good performance across databases. For COVID‐19, incidence calculated by the package was similar to public data after the first‐wave of the pandemic.

Conclusion

For data mapped to the OMOP CDM, the IncidencePrevalence R package can support descriptive epidemiological research. It enables reliable estimation of incidence and prevalence from large real‐world data sets. It represents a simple, but extendable, analytical framework to generate estimates in a reproducible and timely manner.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Data ManagementCOVID-19HumansIncidencePrevalenceDatabases, Factual

Stichwörter der Autor:innen

OMOPR packagecommon data modelincidenceprevalence

Autor:innen und Institutionen

  • Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain.
  • Universitat Autònoma de Barcelona, Bellaterra (Cerdanyola del Vallès), Barcelona, Spain.
  • Centre for Statistics in Medicine (CSM), Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDROMS), University of Oxford, Oxford, UK.
  • Odysseus Data Services, Cambridge, Massachusetts, USA.
  • Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands.

ORCID-Profile: Berta Raventós, Martí Català, Mike Du, Yuchen Guo, Adam Black, Ger Inberg, Xintong Li, Kim López-Güell, Danielle Newby, Maria de Ridder, Cesar Barboza, Talita Duarte-Salles, Katia Verhamme, Peter Rijnbeek, Daniel Prieto Alhambra, Edward Burn

Förderung

  • European Medicines Agency

Zitieren

APA

Raventós, B., Català, M., Du, M., Guo, Y., Black, A., Inberg, G., Li, X., López-Güell, K., Newby, D., de Ridder, M., Barboza, C., Duarte-Salles, T., Verhamme, K., Rijnbeek, P., Prieto Alhambra, D., & Burn, E. (2024). IncidencePrevalence : An R package to calculate population‐level incidence rates and prevalence using the OMOP common data model. Pharmacoepidemiology and Drug Safety, 33(1). https://doi.org/10.1002/pds.5717

Vancouver

Raventós B, Català M, Du M, Guo Y, Black A, Inberg G, et al. IncidencePrevalence : An R package to calculate population‐level incidence rates and prevalence using the OMOP common data model. Pharmacoepidemiology and Drug Safety. 2024;33(1). doi:10.1002/pds.5717

BibTeX
@article{Ravents2024,
  author = {Raventós, Berta and Català, Martí and Du, Mike and Guo, Yuchen and Black, Adam and Inberg, Ger and Li, Xintong and López-Güell, Kim and Newby, Danielle and de Ridder, Maria and Barboza, Cesar and Duarte-Salles, Talita and Verhamme, Katia and Rijnbeek, Peter and Prieto Alhambra, Daniel and Burn, Edward},
  title = {IncidencePrevalence : An R package to calculate population‐level incidence rates and prevalence using the OMOP common data model},
  journal = {Pharmacoepidemiology and Drug Safety},
  year = {2024},
  volume = {33},
  number = {1},
  doi = {10.1002/pds.5717}
}
Kostenlos starten →